Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anatomic Stage II Breast Cancer AJCC v8”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnded earlyNCT00503841
What this trial is testing

Erlotinib in Treating Women Undergoing Surgery For Stage I, Stage II, or Stage III Breast Cancer

Who this might be right for
Breast Cancer
Barbara Ann Karmanos Cancer Institute 44
Testing effectiveness (Phase 2)Study completedNCT00499083
What this trial is testing

Paclitaxel, Cyclophosphamide & Doxorubicin, Autologous Dendritic Cells & Surgery in Stage II/III Breast Cancer (Women)

Who this might be right for
Breast Cancer
University of Nebraska 17
Not applicableStudy completedNCT00665782
What this trial is testing

Measuring Stress in Women With Newly Diagnosed Stage I, Stage II, or Stage III Breast Cancer or Ductal Carcinoma In Situ of the Breast

Who this might be right for
Anxiety DisorderBreast CancerDepression+1 more
Wake Forest University Health Sciences 24
Large-scale testing (Phase 3)Active Not RecruitingNCT01953588
What this trial is testing

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

Who this might be right for
Estrogen Receptor-positive Breast CancerHER2-negative Breast CancerInvasive Ductal Breast Carcinoma+6 more
Alliance for Clinical Trials in Oncology 1,473
Testing effectiveness (Phase 2)Ended earlyNCT04216472
What this trial is testing

Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
M.D. Anderson Cancer Center 6
Not applicableUnknownNCT01420185
What this trial is testing

Identification of Genes That Predict Local Recurrence in Samples From Patients With Breast Cancer Treated on NSABP-B-28

Who this might be right for
Breast Cancer
NSABP Foundation Inc 1,300
Not applicableStudy completedNCT01564368
What this trial is testing

DWI in Assessing Treatment Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy

Who this might be right for
Breast Cancer
American College of Radiology Imaging Network 406
Testing effectiveness (Phase 2)Study completedNCT00633750
What this trial is testing

Erlotinib in Treating Patients With Breast Cancer That Can Be Removed by Surgery

Who this might be right for
Breast Cancer
Vanderbilt-Ingram Cancer Center 50
Not applicableStudy completedNCT02002533
What this trial is testing

Brief Behavioral Therapy in Improving Sleep Disorders in Patients With Stage I-III Breast Cancer Undergoing Chemotherapy

Who this might be right for
Sleep DisorderStage IA Breast CancerStage IB Breast Cancer+4 more
Gary Morrow 71
Not applicableActive Not RecruitingNCT06633926
What this trial is testing

Integrative Approaches for Cancer Survivorship (IACS3)

Who this might be right for
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8
University of California, San Francisco 107
Large-scale testing (Phase 3)Study completedNCT01805076
What this trial is testing

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Who this might be right for
Estrogen Receptor-negative Breast CancerProgesterone Receptor-negative Breast CancerStage IA Breast Cancer+3 more
Alliance for Clinical Trials in Oncology 319
Large-scale testing (Phase 3)Study completedNCT00054587
What this trial is testing

Combination Chemotherapy With or Without Trastuzumab in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 3,010
Not applicableStudy completedNCT00900133
What this trial is testing

Study of Calgranulin A/B Levels in Patients With Newly Diagnosed Stage I,II,III Breast Cancer

Who this might be right for
Breast Cancer
Case Comprehensive Cancer Center 60
Large-scale testing (Phase 3)UnknownNCT00003678
What this trial is testing

Tamoxifen in Treating Women With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital Birmingham 20,000
Large-scale testing (Phase 3)UnknownNCT00070278
What this trial is testing

Neoadjuvant Epirubicin, Cyclophosphamide, and Paclitaxel With or Without Gemcitabine in Treating Women Who Are Undergoing Surgery for Early Breast Cancer

Who this might be right for
Breast Cancer
Cambridge University Hospitals NHS Foundation Trust 800
Testing effectiveness (Phase 2)Study completedNCT00562718
What this trial is testing

Capecitabine and Radiation Therapy in Treating Patients With Nonmetastatic Breast Cancer After Surgery

Who this might be right for
Breast Cancer
University of Texas Southwestern Medical Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT06910761
What this trial is testing

Photon Craniospinal Irradiation for the Treatment of Leptomeningeal Disease Secondary to Breast Cancer or Non-small Cell Lung Cancer

Who this might be right for
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Breast CarcinomaMetastatic Lung Non-Small Cell Carcinoma+2 more
City of Hope Medical Center 35
Testing effectiveness (Phase 2)Active Not RecruitingNCT00909909
What this trial is testing

Radiation Therapy in Treating Women With Early Stage Breast Cancer

Who this might be right for
Breast Cancer
Rutgers, The State University of New Jersey 200
Large-scale testing (Phase 3)Study completedNCT00630032
What this trial is testing

Safety and Efficacy Comparison of Docetaxel and Ixabepilone in Non Metastatic Poor Prognosis Breast Cancer

Who this might be right for
Breast Cancer
UNICANCER 762
Not applicableStudy completedNCT00072293
What this trial is testing

Surgical Resection With or Without Axillary Lymph Node Dissection in Treating Women With Node-Negative Breast Cancer and Sentinel Lymph Node Micrometastases

Who this might be right for
Breast Cancer
ETOP IBCSG Partners Foundation 931
Next Page